Analyses demonstrated significantly restricted tumor growth in SF-25 IgE-treated mice, both in relation to the number of metastatic foci (p=0.0028) and with regard to the area of tumor occupancy in animal lungs (p=0.0061) compared with PBMC treated controls (figure 7C, D). The gene discussed is IGHE; the disease is neoplasm.